The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Equity Fundraise

21 Jun 2021 09:00

RNS Number : 5138C
daVictus plc
21 June 2021
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED THEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLYOR INDIRECTLY IN OR INTO AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF ANY RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN DAVICTUS PLC OR ANY OTHER ENTITY IN ANY SUCH JURISDICTION.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

 

21 June 2021

 

daVictus plc

("daVictus")

 

EQUITY FUNDRAISE

 

Davictus Plc ("Davictus" or the "Company") announces it has completed (subject to certain conditions) an equity fundraise of £36,000 (gross) (the "Fundraise") through the issue of 1,200,000 ordinary shares of no par value (the "Fundraise Shares") at a price of 3.0 pence per ordinary share.

 

The Fundraise has been undertaken by way of a placing of new ordinary shares ("Placing") of no par value ("Ordinary Shares") in the share capital of the Company and was arranged by Optiva Securities Limited ("Optiva") with its clients. The Fundraise is to provide additional working capital for the Company.

 

The Fundraise has been undertaken by means of the Placing pursuant to which, the Company will issue 1,200,000 ordinary shares at a price of 3.0p per new ordinary share, based on closing price of the ordinary shares on 18 June 2021 (being the last practicable dealing date prior to the pricing of this transaction).

 

Following admission of the Fundraising Shares to the standard listing segment of the Official List of the Financial Conduct Authority ("FCA") and to trading on the Main Market of the London Stock Exchange, which is expected to occur at 8.00 am on the 29th June 2021, the total number of Ordinary Shares in the Company will be 13,350,000. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For more information please visit the Company's website at www.davictus.co.uk.

 

End

 

For further information, please contact:

 

Investor Relations Team

ir@davictus.co.uk

 

Jeremy King

Optiva Securities Limited

Tel: +44(0)203 137 1904

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEPPUBWQUPGUCG

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.